| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6d77e120d1588e76c73afc1a3197a126 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-622
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-3084
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-46 |
| filingDate |
2004-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_84dedf3a3ed810506318185ffb90dc09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc9b7ae5024af983f925e6e8aebec8ca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e937f359ee48de996a495bab638a8d15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee8892a61dd0181603fd294e75705311
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34d5b57856f919bcd63780efb95a35a1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a116544520c2b9b5abb997d6b62d7cf8 |
| publicationDate |
2006-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
MX-PA05011368-A |
| titleOfInvention |
RECOMBINANT ANTIBODIES AND FRAGMENTS RECOGNIZING GANGLIOSIDE N-GLICOLIL GM3 AND ITS USE FOR DIAGNOSIS AND TUMOR TREATMENT. |
| abstract |
The present invention relates primarily to the production of less immunogenic immunoglobulins by genetic engineering, and more specifically to a monoclonal antibody that recognizes antigens containing the ganglioside N-glycolyl GM3 and no other gangliosides of the N-glycolyl or N type -acetyl, or sulfated glycolipids. More specifically, the present invention relates to the peptide sequences encoding a recombinate monoclonal antibody against the n-glycolyl GM3 ganglioside, or fragments derived therefrom and pharmaceutical compositions containing said antibody or its fragments and its diagnostic or therapeutic use in breast cancer. and melanoma |
| priorityDate |
2003-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |